Objectives: Patients residing in prisons are a vulnerable group with more complex health needs and higher prevalence of inappropriate prescribing than the general population. Overcrowding in prisons, inadequate staffing levels, diversion of medication and substance misuse present challenges to prison healthcare. Interventions that use prescribing safety indicators are one way of helping to reduce the risk of harm by identifying patients at risk of potentially hazardous prescribing. This qualitative study aimed to understand the implementation and impact of a suite of seven prescribing safety indicators, specifically developed for use in prison settings, as part of a multi-disciplinary intervention.
Design And Setting: Semistructured interviews were conducted with a range of prison healthcare staff across 30 different prison sites in England. In addition, an online survey was made available to all healthcare staff in participating prisons. Data analysis of interview transcripts and free-text survey responses was conducted following a thematic approach and informed by normalisation process theory.
Participants: Interviews were conducted with 9 prison healthcare staff and 40 completed the survey, with 18 staff providing free-text responses.
Results: Three themes were interpreted from the data: bringing people together and establishing individual and collective roles that facilitated implementation of the intervention; developing new tasks, work processes and practices to make the intervention work in everyday practice; and seeing the benefits and value of the intervention and new work processes within the context of prison healthcare provision.
Conclusions: New work processes and practices were instigated in order to implement the intervention, often fitting into existing medication safety practices, building on other prescribing work and creating learning across the team. While we found that prison staff reported challenges to implementation, similar interventions may be used for prescribing safety in prison settings.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11883610 | PMC |
http://dx.doi.org/10.1136/bmjopen-2024-086309 | DOI Listing |
Health Sci Rep
March 2025
Department of Veterinary Medicine, Faculty of Veterinary Medicine University of Ibadan Ibadan Nigeria.
Background: Hepatitis B is one of the major global health issues, which presents a particularly severe challenge within the confines of African prisons, characterized by high rates of transmission and limited access to adequate healthcare. The prevalence of Hepatitis B in these settings represents a silent crisis.
Objective: This research highlights the critical public health emergency posed by Hepatitis B in African prisons, underscoring the need for urgent intervention and comprehensive strategies.
Sci Rep
March 2025
AUSL - U.O.S.D. Oncology Screenings, Epidemiology and Health Promotion Programs, Local Health Agency of Ferrara, Corso Giovecca 203, 44121, Ferrara, Italy.
Hepatitis C virus (HCV) is a worldwide health hazard, and in chronic form (nowadays affecting 50 million people - World Health Organization data) can be lethal. To forestall it, preventive screening is a mandatory approach. Since 2021, Italy conducts a national-wide screening program to eliminate the virus from its population.
View Article and Find Full Text PDFBMJ Open
March 2025
National Institute for Health and Care Research (NIHR) Greater Manchester Patient Safety Research Collaboration (GM PSRC), The University of Manchester, Manchester, UK.
Objectives: Patients residing in prisons are a vulnerable group with more complex health needs and higher prevalence of inappropriate prescribing than the general population. Overcrowding in prisons, inadequate staffing levels, diversion of medication and substance misuse present challenges to prison healthcare. Interventions that use prescribing safety indicators are one way of helping to reduce the risk of harm by identifying patients at risk of potentially hazardous prescribing.
View Article and Find Full Text PDFBMC Infect Dis
February 2025
Department of Pharmacy Practice, University of Illinois Chicago, Chicago, IL, USA.
Background: It is known that SARS-CoV-2 infection increases the risk of severe illness in patients who are immunocompromised as compared to the general public. To combat this issue, telemedicine was utilized to combat the issue of general access to care to decrease the risk of exposure of SARS-CoV-2 infection in various settings. However, there is very little data on adequate continuity of care (COC) and sustainability of telehealth throughout the SARS-CoV-2 pandemic.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!